πππππππππ ππ π
πππ πππππ.
One of the first iterations of craneβs compound was synthesized to have an amnesia - like quality so that volunteers participating in his experiments were protected from the emotional and psychological consequences of re - visiting traumatic experiences, as well as to conceal the equivocal ethics of his experiments.
He used this water - soluable, powdered, drug to help treat participants that have been diagnosed with phobias and anxiety disorders. Claiming that by observing an individualβs behavior as they recounted or re - lived a traumatizing past experience, the root of their insecurity or fear could be identified and they could be counseled to confront it.
Unfortunately, because participants had no memory of the events that transpired after they were drugged, no progress was made at the close of each trial β except for a few participants who were unlucky enough to experience β flashbacks β ( night terrors ) during their sleep.
This prompted Crane to discontinue the use of his drug prompting memory loss and to focus his attention on accessing the subconscious through chemical means so that, rather than asking participants to describe their dreams, he could record their response to terrifying visions firsthand.
8 notes
Β·
View notes